stolic dysfunction, preserved systolic function). Infiltrative processes, toxic causes, infections
of the myocardium, and systemic conditions, such as collagen vascular diseases with …

BACKGROUND: Community and hospital studies have suggested that survival of patients
with heart failure (HF) has increased; however, the causes of the improvement and the …

Objectives: We sought to evaluate the characteristics, treatments, and outcomes of patients
with preserved and reduced systolic function heart failure (HF). Background: Heart failure …

BACKGROUND: Available data suggest that improvement in left ventricular ejection fraction
(LVEF) is a major predictor of improved survival in heart failure (HF). Although certain factors …

There are now a number of guidelines outlining the diagnosis and management of patients
with chronic heart failure (CHF). The extent to which these guidelines are used and the …

Background Heart failure and left ventricular systolic dysfunction (LVSD) are increasingly
common disorders, with outcomes worse than many cancers. Evidence-based therapies …

Background: Congestive heart failure is the leading cause of hospital admissions for adults
in the United States. To our knowledge, there are limited data comparing the clinical …

1784 FONAROW GC et al. disease management programs have been shown to improve
clinical outcomes. 9–11 However, despite extensive clinical trial experience and …

Patients with congestive heart failure (CHF) and preserved systolic function are very
common. Despite the high prevalence of this syndrome, very little information is known …

Background: Despite major advances in the pharmacotherapy of heart failure,
hospitalization rates remain high, owing in large part to a multitude of psychosocial …